Long-term outcomes after elective inguinal hernia mesh-repair in patients with inflammatory bowel disease
-
By
-
Hans Lovén
-
Rune Erichsen
-
Anders Tøttrup
-
Thue Bisgaard
-
May 23, 2025
-
Clinical Scorecard: Long-term Results of Elective Inguinal Hernia Mesh Repair in Individuals with Inflammatory Bowel Disease
At a Glance
| Category | Detail |
| Condition | Inflammatory Bowel Disease (IBD) including Crohn's Disease (CD), Ulcerative Colitis (UC), and unclassified IBD (IBD-U) |
| Key Mechanisms | Mesh-related complications such as enteric fistulas interacting with synthetic mesh implants leading to chronic infections and reoperations |
| Target Population | Patients with IBD undergoing elective inguinal hernia mesh repair |
| Care Setting | Surgical care in hospital settings performing elective inguinal hernia mesh repair |
Key Highlights
- Patients with Crohn's Disease have a higher risk of mesh-related complications and hernia recurrence compared to those with UC or IBD-U.
- Fistulising disease (perianal and intra-abdominal) contributes to increased surgical complications in CD patients.
- Open (Lichtenstein) and laparoscopic (TAPP) mesh repair techniques were analyzed, excluding other less common methods.
Guideline-Based Recommendations
Diagnosis
- Use ICD-10 and Nordic Medico-Statistical Committee codes to classify IBD subtypes and fistulising disease.
- Confirm IBD diagnosis and subtype via validated national registries and medical records.
Management
- Elective inguinal hernia mesh repair should consider IBD subtype, especially presence of fistulising disease in CD patients.
- Prefer standardized surgical techniques (Lichtenstein or TAPP) for mesh repair in IBD patients.
- Avoid acute hernia repairs and non-standard mesh repair techniques in this population.
Monitoring & Follow-up
- Monitor for mesh-related complications and hernia recurrence from 30 days post-operation through long-term follow-up.
- Classify complications using Clavien-Dindo grading system.
- Manual review of reoperations is recommended to assess mesh-related complications accurately.
Risks
- Higher risk of chronic mesh infections, enteric fistulas, and repeated reoperations in CD patients.
- Potentially fatal outcomes associated with mesh-related complications in IBD patients.
- Increased risk of recurrence and complications in patients with fistulising disease.
Patient & Prescribing Data
IBD patients undergoing elective inguinal hernia mesh repair, including those on anti-TNF-α therapy.
Anti-TNF-α medication use within three months prior to surgery was documented; impact on complications was considered in analysis.
Clinical Best Practices
- Ensure comprehensive preoperative assessment of IBD subtype and fistulising disease status.
- Use validated national registries and manual medical record review for accurate diagnosis and complication tracking.
- Select appropriate surgical technique (Lichtenstein or TAPP) based on patient characteristics and surgeon expertise.
- Implement long-term follow-up protocols to detect and manage mesh-related complications and hernia recurrence.
- Exclude patients with acute hernia repair or non-standard mesh repair techniques from elective surgery cohorts.
References